182 related articles for article (PubMed ID: 32585195)
21. Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma.
Samuel J; Singh N; Kanwar JR; Krishnakumar S; Kanwar RK
Exp Eye Res; 2015 Oct; 139():108-14. PubMed ID: 26213306
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
Wu XZ; Cui HP; Lv HJ; Feng L
Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
[TBL] [Abstract][Full Text] [Related]
23. Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma.
Balaji S; Rao A; Saraswathi KK; Sethu Nagarajan R; Santhi R; Kim U; Muthukkaruppan V; Vanniarajan A
Med Oncol; 2024 Jun; 41(7):168. PubMed ID: 38834895
[TBL] [Abstract][Full Text] [Related]
24. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway.
Liu F; Zhang Q; Liang Y
J Cell Biochem; 2020 Mar; 121(3):2294-2302. PubMed ID: 31674056
[TBL] [Abstract][Full Text] [Related]
26. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
27. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
[TBL] [Abstract][Full Text] [Related]
28. KLF16 overexpression deleteriously affects the proliferation and migration of retinoblastoma by transcriptionally repressing BCL2L15.
Zhang JX; Yan XJ; Wu S; Liu Q; Ma JM
Biochem Biophys Res Commun; 2020 Sep; 529(4):977-983. PubMed ID: 32819608
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.
Li W; Wang J; Zhang D; Zhang X; Xu J; Zhao L
Cancer Biomark; 2019; 25(1):79-88. PubMed ID: 31033463
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of MST4 Underlies a Novel Inhibitory Role of MicroRNA Let-7a in the Progression of Retinoblastoma.
Zhang X; Song L; Huang Y; Han S; Hou M; Li H
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):28. PubMed ID: 32539131
[TBL] [Abstract][Full Text] [Related]
31. microRNA -378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1.
Zhang C; Wu S
Invest Ophthalmol Vis Sci; 2020 May; 61(5):31. PubMed ID: 32428232
[TBL] [Abstract][Full Text] [Related]
32. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
33. miR-29a inhibits human retinoblastoma progression by targeting STAT3.
Liu S; Zhang X; Hu C; Wang Y; Xu C
Oncol Rep; 2018 Feb; 39(2):739-746. PubMed ID: 29251322
[TBL] [Abstract][Full Text] [Related]
34. The apoptotic and anti-proliferative effect of Lysyl oxidase propeptide in Y79 human retinoblastoma cells.
Nagaraj NR; Natarajan SK; Karunakaran C
Mol Vis; 2023; 29():125-139. PubMed ID: 38222455
[TBL] [Abstract][Full Text] [Related]
35. Triggering p53 activation is essential in ziyuglycoside I-induced human retinoblastoma WERI-Rb-1 cell apoptosis.
Zhu X; Wang K; Yao Y; Zhang K; Zhou F; Zhu L
J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 28960612
[TBL] [Abstract][Full Text] [Related]
36. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
Markey MP; Bergseid J; Bosco EE; Stengel K; Xu H; Mayhew CN; Schwemberger SJ; Braden WA; Jiang Y; Babcock GF; Jegga AG; Aronow BJ; Reed MF; Wang JY; Knudsen ES
Oncogene; 2007 Sep; 26(43):6307-18. PubMed ID: 17452985
[TBL] [Abstract][Full Text] [Related]
37. LncRNA TP73-AS1 down-regulates
Xia Z; Yang X; Wu S; Feng Z; Qu L; Chen X; Liu L; Ma Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015368
[TBL] [Abstract][Full Text] [Related]
38. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
39. Effects of miR-26a on the expression of Beclin 1 in retinoblastoma cells.
Li M; Chen XM; Wang DM; Gan L; Qiao Y
Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421000
[TBL] [Abstract][Full Text] [Related]
40. Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors.
Babu VS; Mallipatna A; Sa D; Dudeja G; Kannan R; Shetty R; Nair AP; Gundimeda S; Chaurasia SS; Verma NK; Lakshminarayanan R; Heymans S; Barathi VA; Guha N; Ghosh A
Cells; 2022 May; 11(10):. PubMed ID: 35626705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
